Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants

Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants
Condition:   Pharmacokinetics
Interventions:   Drug: ESK-001;   Drug: Rabeprazole
Sponsor:   Alumis Inc
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 16, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments